Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INXBTC

(INXBTC)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
07/05/20244:10PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
07/05/20244:10PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
07/05/20244:10PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
07/05/20244:10PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
07/05/20244:10PMGlobeNewswire Inc.National Bank Holdings Corporation Announces Date for 2024 Second Quarter Earnings ReleaseNYSE:NBHCNational Bank Holdings Corporation
07/05/20244:10PMAlliance NewsAlliance NewsIN BRIEF: Record PLC chair Morrison's investment company buys sharesLSE:RECRecord Plc
07/05/20244:10PMPR Newswire (US)Spray Gun Market size is set to grow by USD 229.8 million from 2024-2028, Growing paints and coatings market boost the market, Technavio
07/05/20244:07PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:XPAXUXPAC Acquisition Corporation
07/05/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HYACUHaymaker Acquisition Corp 4
07/05/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SSNTSilverSun Technologies Inc
07/05/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XPAXUXPAC Acquisition Corporation
07/05/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:FACTFreedom Acquisition I Corp
07/05/20244:05PMPR Newswire (US)Dominion Energy Schedules Second-Quarter 2024 Earnings CallNYSE:DDominion Energy Inc
07/05/20244:05PMGlobeNewswire Inc.Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred StockNASDAQ:FBIOFortress Biotech Inc
07/05/20244:05PMGlobeNewswire Inc.Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred StockNASDAQ:FBIOPFortress Biotech Inc
07/05/20244:05PMPR Newswire (US)Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SNDXSyndax Pharmaceuticals Inc
07/05/20244:05PMPR Newswire (US)IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024NASDAQ:IDYAIDEAYA Biosciences Inc
07/05/20244:05PMGlobeNewswire Inc.Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CMRXChimerix Inc
07/05/20244:05PMBusiness WireEnterprise Financial Services Corp Announces Second Quarter 2024 Earnings Release and Conference CallNASDAQ:EFSCEnterprise Financial Services Corporation
07/05/20244:03PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJJP Morgan Alerian MLP
07/05/20244:02PMPR Newswire (US)ProLux Announces Sponsorship of Rising Boxing Star Brady Ochoa
07/05/20244:01PMBusiness WireAtara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
07/05/20244:01PMBusiness WireSkyWest, Inc. Announces Second Quarter 2024 Results Call DateNASDAQ:SKYWSkyWest Inc
07/05/20244:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BSGMBioSig Technologies Inc
07/05/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BSGMBioSig Technologies Inc
07/05/20244:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BSGMBioSig Technologies Inc
07/05/20244:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BSGMBioSig Technologies Inc
07/05/20244:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BSGMBioSig Technologies Inc
07/05/20244:00PMGlobeNewswire Inc.Inventiva fait le point sur son programme clinique NATiV3 évaluant lanifibranor dans la MASH/NASH et sur sa situation financièrEU:IVAInventiva
07/05/20244:00PMGlobeNewswire Inc.Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position  TG:6IVInventiva